Many authors propose the detection of IL-8 in the Bronchoalveolar lavage fluid (BALF) as a prognostic factor in patients at risk for non-COVID-19 ARDS, as well as predicting patient outcomes. This evidence concerns the gene CXCL8 and COVID-19.